<DOC>
	<DOCNO>NCT01160848</DOCNO>
	<brief_summary>Open , prospective , randomize , single-centre study patient moderate severe facial acne vulgaris . Three circular area diameter 4 cm , circle include least 4 inflammatory lesion , select acne-affected area face . One area identify cheek one area identify forehead . The minimum distance three area least 4 cm . For patient three area randomize either pre-treatment cleaning use wipe contain ethyl alcohol solution ( one area ) cleanse wipe contain saline water ( two area ) , application Visonac cream . One area clean saline wipe also occlude transparent dressing ( Tegaderm ) incubation time . In vivo fluorescence spectroscopy perform three area cream application , 1h , 1.5h , 2h , 2.5h 3 h cream application . After last fluorescence spectroscopy reading , cream wipe patient protect three area sunlight , prolong , intense light 2 day . The study extend additionally 8 patient explore photoactive porphyrin level 24 hour period : The patient clean face Cetaphil Gentle Skin Cleanser cream application . For patient three area randomize Visonac 80mg leave skin 24 hour Visonac ( MAL8 % ) wipe 1 hour . In vivo fluorescence spectroscopy perform three area cream application , 2h , 3 h , 4h , 5h , 8h , 10h , 11h , 12h , 13h , 15 24h cream application . The exact time point may adjust base result previously include patient . All patient instruct protect three area sunlight , prolong , intense light 2 day .</brief_summary>
	<brief_title>Photoactive Porphyrins ( PAP ) Levels After Topical Visonac Application Acne Patients</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Signed verify informed consent form . For patient age 18 , assent form conjunction inform consent form , sign verified parent/guardian . Adolescent adult female male patient , 12 35 year age . Patients moderate severe facial acne vulgaris accord IGA scale . Female patient surgically sterile , premenstrual , postmenopausal , abstinent , willing use adequate mean contraception include birth control pill , barrier method spermicide least 14 day prior study visit . Patients skin type II III ( Fitzpatrick ) . Patients 3 area 4 cm diameter , include least least 4 inflammatory lesion ( papule , pustule , nodule ) face ( cheek forehead ) . Subject investigator sub investigator , research assistant , pharmacist , study coordinator , staff relative thereof directly involve conduct protocol . Patients unlikely comply protocol , e.g . mental condition render patient unable understand nature , scope , possible consequence clinical study , uncooperative attitude unlikelihood complete study ( e.g . drug alcohol abuse ) . Female subject childbearing potential ( i.e . ovulation , premenopausal , surgically sterilize ) willing use medically accept contraceptive regimen treatment . Pregnancy Lactating . Participation clinical study either currently within last 30 day . Patients porphyria . Known allergy ( MAL ) , similar PDT compound , excipients cream Patients cutaneous photosensitivity . Patients receive topical treatment acne within last 14 day . Medicated cleanser contain active ingredient 5 % BPO high concentration salicylic acid may stop treatment . ( Cosmetic Cleansers contain 2 % salicylic acid allow ) . Patients receive oral antibiotic treatment acne within last month . Patients receive oral isotretinoin within last 6 month . Patients beard might interfere study assessment . Patients melanoma dysplastic nevus treatment area</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Moderate severe Acne Vulgaris</keyword>
</DOC>